Anonymous ID: b8c28e Oct. 16, 2021, 3:47 p.m. No.14798664   🗄️.is đź”—kun   >>9062

>>14798623

In this case, as long as she meets one of the high-risk criteria she qualifies for PEP treatment per EUA.

 

Her doctor should have given her PEP via another highly efficient method if really concerned about her progressing rapidly due to risk factors…

I MASK+…

 

They should look into Ivermectin and HCQ synergism. Could be another golden combo.

Anonymous ID: b8c28e Oct. 16, 2021, 4:29 p.m. No.14798886   🗄️.is đź”—kun   >>9009

>>14798623

Thought about it further….

In this scenario she has tested positive… who knows what test?

but since she tested positive as long as she is high risk she qualifies for treatment.

 

Treatment

This EUA is for the use of the unapproved product, REGEN-COV (casirivimab and imdevimab) co-formulated product and REGEN-COV (casirivimab and imdevimab) supplied as individual vials to be administered together, for the treatment of mild to moderate COVID-19 in adult and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death [see Limitations of Authorized Use (1.1)].

 

Post-Exposure Prophylaxis

This EUA is for the use of the unapproved product, REGEN-COV (casirivimab and

imdevimab) co-formulated product and REGEN-COV (casirivimab and imdevimab)

supplied as individual vials to be administered together, in adult and pediatric individuals (12 years of age and older weighing at least 40 kg) for post-exposure

prophylaxis of COVID-19 in individuals who are at high risk for progression to

severe COVID-19, including hospitalization or death, and are:

 

• not fully vaccinated or who are not expected to mount an adequate immune

response to complete SARS-CoV-2 vaccination (for example, individuals with

immunocompromising conditions including those taking immunosuppressive

medications) and

  • have been exposed to an individual infected with SARS-CoV-2

consistent with close contact criteria per Center for Disease Control

and Prevention (CDC)3 or

  • who are at high risk of exposure to an individual infected with SARS-

CoV-2 because of occurrence of SARS-CoV-2 infection in other

individuals in the same institutional setting (for example, nursing

homes, prisons) [see Limitations of Authorized Use (1.2)]

 

This is tricky.

 

If you are vaccinated you would need to qualify under ….'who are not expected to mount an adequate immune response'….

 

If you are vaccinated and your immune system takes a hit from the poisioning, does that let you qualify?